R.J. Bryant

818 total citations
15 papers, 589 citations indexed

About

R.J. Bryant is a scholar working on Molecular Biology, Oncology and Orthopedics and Sports Medicine. According to data from OpenAlex, R.J. Bryant has authored 15 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Orthopedics and Sports Medicine. Recurrent topics in R.J. Bryant's work include Bone Metabolism and Diseases (6 papers), Bone health and treatments (5 papers) and Bone health and osteoporosis research (4 papers). R.J. Bryant is often cited by papers focused on Bone Metabolism and Diseases (6 papers), Bone health and treatments (5 papers) and Bone health and osteoporosis research (4 papers). R.J. Bryant collaborates with scholars based in United States and United Kingdom. R.J. Bryant's co-authors include Connie M. Weaver, William C. Dougall, Martine P. Roudier, Jude Canon, Berdine R. Martin, Sean Morony, Paul J. Kostenuik, Marina Stolina, George P. McCabe and Munro Peacock and has published in prestigious journals such as American Journal of Clinical Nutrition, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.

In The Last Decade

R.J. Bryant

14 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.J. Bryant United States 9 228 208 169 126 106 15 589
Osamu Chaki Japan 13 302 1.3× 307 1.5× 472 2.8× 148 1.2× 56 0.5× 22 834
MP Lecart Belgium 11 184 0.8× 166 0.8× 312 1.8× 62 0.5× 59 0.6× 27 519
V Pacovský Czechia 16 372 1.6× 386 1.9× 516 3.1× 187 1.5× 74 0.7× 47 1.2k
J. Birmingham Australia 6 244 1.1× 190 0.9× 425 2.5× 135 1.1× 34 0.3× 8 709
Uģis Gruntmanis United States 11 182 0.8× 208 1.0× 210 1.2× 64 0.5× 15 0.1× 26 522
Lawrence Flora United States 7 153 0.7× 50 0.2× 154 0.9× 51 0.4× 60 0.6× 7 357
Kyongchol Kim South Korea 9 99 0.4× 288 1.4× 109 0.6× 70 0.6× 40 0.4× 11 620
D. Jenkins United States 6 242 1.1× 171 0.8× 310 1.8× 82 0.7× 39 0.4× 7 515
Simon Lykkeboe Denmark 10 189 0.8× 265 1.3× 315 1.9× 85 0.7× 31 0.3× 19 590
Stefania Di Bella Italy 7 171 0.8× 280 1.3× 195 1.2× 45 0.4× 24 0.2× 10 461

Countries citing papers authored by R.J. Bryant

Since Specialization
Citations

This map shows the geographic impact of R.J. Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.J. Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.J. Bryant more than expected).

Fields of papers citing papers by R.J. Bryant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.J. Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.J. Bryant. The network helps show where R.J. Bryant may publish in the future.

Co-authorship network of co-authors of R.J. Bryant

This figure shows the co-authorship network connecting the top 25 collaborators of R.J. Bryant. A scholar is included among the top collaborators of R.J. Bryant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.J. Bryant. R.J. Bryant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Canon, Jude, R.J. Bryant, Martine P. Roudier, & William C. Dougall. (2013). Abstract 3947: AMG 161, a fully human monoclonal antibody to human RANKL, inhibits tumor-induced osteoclastogenesis and reduces skeletal tumor burden in mice that express chimeric (murine / human) RANKL.. Cancer Research. 73(8_Supplement). 3947–3947. 1 indexed citations
3.
Bryant, R.J., Traci Pawlowski, James W.F. Catto, et al.. (2012). 435 Circulating microRNAs are associated with the development and progression of prostate cancer. European Urology Supplements. 11(1). e435–e435a. 1 indexed citations
4.
Canon, Jude, R.J. Bryant, Martine P. Roudier, Daniel Branstetter, & William C. Dougall. (2012). RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model. Breast Cancer Research and Treatment. 135(3). 771–780. 28 indexed citations
5.
Canon, Jude, R.J. Bryant, Martine P. Roudier, et al.. (2010). Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis. Bone. 46(6). 1613–1619. 30 indexed citations
6.
Martin, Berdine R., Michelle Braun, Karin Wigertz, et al.. (2010). Fructo-Oligosaccharides and Calcium Absorption and Retention in Adolescent Girls. Journal of the American College of Nutrition. 29(4). 382–386. 30 indexed citations
7.
Canon, Jude, R.J. Bryant, Robert E. Miller, et al.. (2008). P13. The RANKL inhibitor OPG-Fc delays the de novo establishment of breast cancer skeletal metastases in an MDA-MB-231 mouse model. Cancer Treatment Reviews. 34. 17–17. 1 indexed citations
8.
Braun, Michelle, Cristina Palacios, Karin Wigertz, et al.. (2007). Racial differences in skeletal calcium retention in adolescent girls with varied controlled calcium intakes. American Journal of Clinical Nutrition. 85(6). 1657–1663. 82 indexed citations
9.
Canon, Jude, Martine P. Roudier, R.J. Bryant, et al.. (2007). Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis. Clinical & Experimental Metastasis. 25(2). 119–129. 154 indexed citations
10.
Bryant, R.J., et al.. (2003). Effects of Vitamin E and C Supplementation Either Alone or in Combination on Exercise-Induced Lipid Peroxidation in Trained Cyclists. The Journal of Strength and Conditioning Research. 17(4). 792–792. 50 indexed citations
11.
Bryant, R.J., Meryl E. Wastney, Berdine R. Martin, et al.. (2003). Racial Differences in Bone Turnover and Calcium Metabolism in Adolescent Females. The Journal of Clinical Endocrinology & Metabolism. 88(3). 1043–1047. 98 indexed citations
12.
Wastney, Meryl E., Berdine R. Martin, R.J. Bryant, & Connie M. Weaver. (2003). Calcium Utilization in Young Women: New Insights from Modeling. Advances in experimental medicine and biology. 537. 193–205. 3 indexed citations
13.
Bryant, R.J., et al.. (2001). Open lateral ligament injuries of the ankle and rock climbing. The Foot. 11(2). 89–90. 1 indexed citations
14.
Bryant, R.J., et al.. (1999). The New Dietary Reference Intakes for Calcium: Implications for Osteoporosis. Journal of the American College of Nutrition. 18(sup5). 406S–412S. 65 indexed citations
15.
Rubin, Janet, et al.. (1996). Regulation of Murine Osteoblast Macrophage Colony-Stimulating Factor Production by 1,25(OH) 2 D 3. Calcified Tissue International. 59(4). 291–296. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026